 |
|
Heparin With and Without Dihydroergotamine in Prevention of Thromboembolic Complications of Major Abdominal SurgeryA Randomized Trial
Peer Wille-Jørgensen, MD;
Johan Kjaergaard, MD, PhD;
Jens Thorup, MD;
Torben Jørgensen, MD;
Jan Fogh, MD, PhD;
Ole Munck, MD, PhD;
Bjørn Andersen, MD, PhD
Arch Surg. 1983;118(8):926-928.
Abstract
• We compared the results of dihydroergotamine mesylate administered with low-dose heparin sodium with those of low-dose heparin given alone in a randomized trial based on 181 patients who underwent major abdominal surgery. We found no significant difference in the incidence of thromboembolism between the two groups but a higher incidence of abnormal fibrinogen uptake test results in patients given heparin alone. There was no difference in hemoglobin levels and the number of blood transfusions. We concluded that there is little, if any, clinical advantage in adding dihydroergotamine to low-dose heparin to prevent thromboembolic complications in patients who have undergone major abdominal surgery.
(Arch Surg 1983;118:926-928)
Author Affiliations
From the Departments of Surgical Gastroenterology (Drs Wille-Jørgensen, Kjaegaard, Thorup, Jørgensen, and Andersen) and Clinical Physiology (Drs Fogh and Munck), Herlev Hospital, University of Copenhagen.
Footnotes
Accepted for publication Nov 11, 1982.
Presented in revised form at the International Symposium on Venous Diseases of the Lower Limbs, Florence, Italy, March 11, 1982.
Reprint requests to Department of Surgical Gastroenterology, Herlev Hospital, DK-2730 Herlev, Denmark (Dr Wille-Jørgensen).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Prevention of Venous Thromboembolism
Geerts et al.
Chest 2001;119
:132S-175S.
FULL TEXT
Prophylaxis of Postoperative Deep Venous Thrombosis
Wille-Jorgensen and Kjaergaard
JAMA 1985;253:1120-1120.
ABSTRACT
|
